Recombinant F. meningosepticum Endo F1 Protein, CF

R&D Systems | Catalog # 5220-GH

R&D Systems
Loading...

Key Product Details

  • R&D Systems E. coli-derived Recombinant F. meningosepticum Endo F1 Protein (5220-GH)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

E. coli

Accession Number

Applications

Enzyme Activity
Loading...

Product Specifications

Source

E. coli-derived f. meningosepticum Endo-beta-N-acetylglucosaminidase F1/Endo F1 protein
Arg31-Trp339, with an N-terminal Met and 6-His tag
Accession # P36911

Purity

>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Met

Predicted Molecular Mass

35 kDa

SDS-PAGE

35 kDa, under reducing conditions

Activity

Measured by its ability to deglycosylate ribonuclease B under native conditions.
The DC50 is < 5 ng. The DC50 is defined as the amount of enzyme required to remove 50% of glycan on 1 μg of RNase B in 30 minutes at
37 °C.. Use of Recombinant F. meningosepticum
Endo F1 in the delycoslyation of other substrates may require alternative conditions for optimal performance.

Formulation, Preparation, and Storage

5220-GH
Formulation Supplied as a 0.2 μm filtered solution in Tris and NaCl.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.

Background: Endo-beta-N-acetylglucosaminidase F1/Endo F1

N-glycans are commonly found on various glycoproteins. While peptide N-glycosidase from Flavobacterium meningosepticum (PNGase F) is widely used to release virtually all types of N-glycans under denaturing conditions, Endo-beta -N-acetylglucosaminidases from the same bacterial species, including Endo F1, can be used under native conditions to specifically release particular types of N-glycans (1, 2). Because these glycosidases hydrolyze the chitobiose core ofN-glycans, the released glycan products will contain one GlcNAc residue at their reducing ends with the other GlcNAc residue remaining attached to an asparagine residue on the glycoprotein. Endo F1 specifically releases oligomannose and hybrid but not complex type N-glycans from glycoproteins (3, 4). This enzyme is also suitable to deglycosylate substrates under denaturing conditions and remains active on sulfated and core fucosylated N-glycans at reduced rates (4).

References

  1. Maley, F. et al. (1989) Anal. Biochem. 180:195.
  2. Tarentino, A.L. et al. (1985) Biochemistry. 24:4665.
  3. Tarentino, A.L. et al. (1992) J. Biol. Chem. 267:3868.
  4. Trimble, R.B. and Tarentino, A.L. (1991) J. Biol. Chem. 266:1646.

Alternate Names

CDC II-a, EndobetaNacetylglucosaminidase F1

UniProt

Additional Endo-beta-N-acetylglucosaminidase F1/Endo F1 Products

Product Documents for Recombinant F. meningosepticum Endo F1 Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant F. meningosepticum Endo F1 Protein, CF

For research use only

Customer Reviews for Recombinant F. meningosepticum Endo F1 Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant F. meningosepticum Endo F1 Protein, CF and earn rewards!

Have you used Recombinant F. meningosepticum Endo F1 Protein, CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

View specific protocols for Recombinant F. meningosepticum Endo F1 Protein, CF (5220-GH):

Materials
  • Assay Buffer: 50 mM Sodium Phosphate, pH 5.5
  • Recombinant F. meningosepticum Endo-beta -N-acetylglucosaminidase F1/Endo F1  (rFmEndo F1) (Catalog # 5220-GH)
  • Substrate: RNase B (Sigma, Catalog # R1153), 1 mg/mL stock in 10 mM Sodium Phosphate, pH 5.5
  • 15% SDS-PAGE gel
  • Reducing SDS-PAGE gel loading buffer
  • Silver Staining reagents
  • BioRad GS-800 densitometer (or equivalent)
  1. Dilute rFmEndo F1 to 2.5, 0.625, 0.156. 0.039, 0.0098, 0.0024, and 0.0006 μg/mL in Assay Buffer.
  2. Dilute Substrate to 100 μg/mL in Assay Buffer.
  3. Combine 10 μL rFmEndo F1 at each dilution with 10 μL of 100 μg/mL Substrate. Include a control containing 10 μL Assay Buffer and 10 μL of 100 μg/mL Substrate.
  4. Incubate the reaction and control at 37 °C for 30 minutes.
  5. Add 20 μL of reducing gel buffer to each reaction. Boil sample at 100 °C for 3 to 5 minutes before loading to gel.
  6. Load all of the sample (40 μL) per lane on a 15% gel. As a staining development control load 25 ng BSA.
  7. Perform electrophoresis.
  8. Stain gel with silver stain, stop stain development when 25 ng BSA becomes visible.
  9. Analyze % deglycosylation by densitometry.
  10. Determine the DC50 for rFmEndo F1 by plotting % Substrate deglycosylated vs. amount with 4-PL fitting.
Per Lane:
  • rFmEndo F1: 25, 6.25, 1.56, 0.39, 0.098, 0.024, and 0.006 ng
  • Substrate: 1 µg

FAQs

No product specific FAQs exist for this product.

View all FAQs for Proteins and Enzymes
Loading...